Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.
Trusheim MR, Shrier AA, Antonijevic Z, Beckman RA, Campbell RK, Chen C, Flaherty KT, Loewy J, Lacombe D, Madhavan S, Selker HP, Esserman LJ. Trusheim MR, et al. Among authors: loewy j. Clin Pharmacol Ther. 2016 Dec;100(6):713-729. doi: 10.1002/cpt.514. Epub 2016 Oct 19. Clin Pharmacol Ther. 2016. PMID: 27643536 Free PMC article.
A framework for assessing the impact of accelerated approval.
Gould AL, Campbell RK, Loewy JW, Beckman RA, Dey J, Schiel A, Burman CF, Zhou J, Antonijevic Z, Miller ER, Tang R. Gould AL, et al. Among authors: loewy jw. PLoS One. 2022 Jun 24;17(6):e0265712. doi: 10.1371/journal.pone.0265712. eCollection 2022. PLoS One. 2022. PMID: 35749431 Free PMC article.
A Practical Guide to Data Monitoring Committees in Adaptive Trials.
Sanchez-Kam M, Gallo P, Loewy J, Menon S, Antonijevic Z, Christensen J, Chuang-Stein C, Laage T. Sanchez-Kam M, et al. Among authors: loewy j. Ther Innov Regul Sci. 2014 May;48(3):316-326. doi: 10.1177/2168479013509805. Ther Innov Regul Sci. 2014. PMID: 30235541
Ethical Considerations in Adaptive Design Clinical Trials.
Laage T, Loewy JW, Menon S, Miller ER, Pulkstenis E, Kan-Dobrosky N, Coffey C. Laage T, et al. Ther Innov Regul Sci. 2017 Mar;51(2):190-199. doi: 10.1177/2168479016667766. Epub 2016 Sep 27. Ther Innov Regul Sci. 2017. PMID: 30231727
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.
Sands BE, Bank S, Sninsky CA, Robinson M, Katz S, Singleton JW, Miner PB, Safdi MA, Galandiuk S, Hanauer SB, Varilek GW, Buchman AL, Rodgers VD, Salzberg B, Cai B, Loewy J, DeBruin MF, Rogge H, Shapiro M, Schwertschlag US. Sands BE, et al. Among authors: loewy j. Gastroenterology. 1999 Jul;117(1):58-64. doi: 10.1016/s0016-5085(99)70550-0. Gastroenterology. 1999. PMID: 10381910 Clinical Trial.
A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer.
Vredenburgh JJ, Hussein A, Fisher D, Hoffman M, Elkordy M, Rubin P, Gilbert C, Kaye JA, Dykstra K, Loewy J, Peters WP. Vredenburgh JJ, et al. Among authors: loewy j. Biol Blood Marrow Transplant. 1998;4(3):134-41. doi: 10.1053/bbmt.1998.v4.pm9923411. Biol Blood Marrow Transplant. 1998. PMID: 9923411 Free article. Clinical Trial.
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.
Isaacs C, Robert NJ, Bailey FA, Schuster MW, Overmoyer B, Graham M, Cai B, Beach KJ, Loewy JW, Kaye JA. Isaacs C, et al. Among authors: loewy jw. J Clin Oncol. 1997 Nov;15(11):3368-77. doi: 10.1200/JCO.1997.15.11.3368. J Clin Oncol. 1997. PMID: 9363868 Clinical Trial.
67 results